YOLFTbeta
Shanghai United Imaging Healthcare Co. Ltd. A

Shanghai United Imaging Healthcare Co. Ltd. A

688271 · SHG · Healthcare / Medical Devices

117.38CNY+1.99 (+1.72%)

Price History

Full chart

Market Stats

Previous Close115.39
Open115.26
Day Range114.30 – 120.18
52-Week Range95.63 – 158.47
Volume6.48M
Market Cap88.49B
P/E (TTM)49.48
Forward P/E33.22
EPS2.17
Dividend Yield0.24%
Beta0.28
50-Day Avg107.62
200-Day Avg116.12

About

Shanghai United Imaging Healthcare Co., Ltd. engages in the provision, development, and production of advanced medical imaging solutions, radiotherapy equipment, life science instruments, and intelligent digital solutions worldwide. The company provides molecular imaging products; and magnetic resonance imaging solutions. It also offers computed tomography equipment; digital radiography equipment; mammography equipment; angiography equipment; mobile C-arm equipment; and radiotherapy systems comprising uRT-linac 506c, uRT-linac 306, and Intelligent RT Cloud Ecosystem. In addition, it provides uVision, a remote vision system that enables real-time positioning observation and automatic field of view identification; a low-dose, 3D mammography platform; and Remote Vision and Exposure Control technology application, a handheld X-ray from UIH that enables accurate positioning while reducing exposure radiation. Further, the company offers United Neuro, a medical imaging software used to analyze functional magnetic resonance imaging and diffusion tensor imaging data, and U-VIEWER, software that helps in viewing DICOM images. Additionally, it provides training, monitoring, maintenance, and troubleshooting services. Shanghai United Imaging Healthcare Co., Ltd. was founded in 2011 and is headquartered in Shanghai, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Zhang Qiang
  • Employees9.30K
  • Headquarters2258 Chengbei Road, Shanghai, China, 201807, China
  • Websitehttps://www.united-imaging.com

Leadership

  • Mr. Zhang QiangChairman & Co-CEO · b. 1969
  • Mr. Shengtan GuoGM, Co-CEO & Director · b. 1963
  • Mr. Bao JunPresident & Director · b. 1965
  • Mr. Jian Bao WangCFO & Head of Finance · b. 1984
  • Mr. Cai TaoBoard Secretary, Chief Investment Officer & Director · b. 1972
  • Mr. Hongdi LiSenior VP, CTO & Core Technician · b. 1967
  • Mr. Fengua XiaSenior Vice President · b. 1970
  • Ms. Yeheng YuSenior Vice President · b. 1979
  • Mr. Hong MiaoSenior Vice President · b. 1972
  • Mr. Yunlei LvVice President · b. 1978

Financials

Income Statement

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue5.76B7.25B9.24B11.41B10.30B13.80B
Growth (%)-+25.91%+27.36%+23.52%-9.73%+33.98%
Cost of Revenue2.96B3.67B4.77B6.04B5.30B7.31B
Gross Profit2.80B3.59B4.47B5.37B5.00B6.49B
Gross Margin48.61%49.42%48.37%47.07%48.54%47.01%
Operating Expense1.60B1.92B2.51B3.38B3.75B4.37B
Operating Income1.20B1.66B1.96B1.99B1.25B2.12B
Operating Margin20.83%22.95%21.19%17.44%12.10%15.36%
EBITDA--2.20B2.49B1.77B2.54B
EBITDA Margin--23.86%21.80%17.15%18.44%
Net Income902.92M1.42B1.66B1.97B1.26B1.87B
Net Income Margin15.67%19.54%17.93%17.30%12.25%13.55%
R&D755.58M968.35M1.31B1.73B1.76B1.84B
R&D as % of Total Revenue13.12%13.35%14.14%15.15%17.10%13.35%
Interest Expense77.73M5.67M6.42M132.52K2.52M5.14M
Interest Expense % of Total Revenue1.35%0.08%0.07%0.00%0.02%0.04%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-9.66B10.36B24.20B25.34B28.04B32.78B
Total Liabilities-6.05B5.33B6.73B6.45B8.13B11.22B
Total Equity-3.60B5.04B17.48B18.87B19.90B21.57B
Cash-3.20B2.92B10.08B7.58B8.40B5.50B
Net Debt108.99M------

Cash Flow

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow3.31B942.45M682.81M132.51M-619.02M2.68B
Capital Expenditure702.57M346.74M741.34M1.08B1.95B2.09B
Free Cash Flow2.61B595.72M-58.52M-943.31M-2.56B585.84M
Dividends Paid56.68M8.11M956.79K165.95M303.60M176.08M
FCF to OCF78.77%63.21%-8.57%-711.88%414.32%21.87%
Dividend Paid to FCF2.17%1.36%-1.63%-17.59%-11.84%30.06%

Earnings

Report DateOct 28, 2022Feb 27, 2023Apr 27, 2023Aug 18, 2023Oct 27, 2023Feb 27, 2024Apr 26, 2024Aug 30, 2024Oct 30, 2024Apr 28, 2025Aug 29, 2025Sep 30, 2025Feb 25, 2026Apr 28, 2026Aug 19, 2026
EPS Estimate0.640.700.590.760.560.700.470.700.280.460.700.420.890.560.60
EPS Actual0.040.940.340.740.061.110.360.61-0.410.450.760.150.930.480.62
Surprise-93.75%34.29%-42.37%-2.63%-89.29%58.57%-23.40%-12.86%-246.43%-2.17%8.57%-64.53%4.49%-14.29%3.33%
TimingPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-market

Key Statistics & Ratios

Market Cap88.49B
Enterprise Value77.10B
Trailing P/E49.48
Forward P/E33.22
Price / Sales5.96
Price / Book3.82
EPS2.17
Book Value26.95
Revenue (TTM)14.84B
Gross Profit (TTM)6.93B
EBITDA2.44B
Profit Margin11.92%
Operating Margin13.16%
Return on Equity8.15%
Return on Assets3.65%
Shares Outstanding824.16M
Shares Float347.28M
Beta0.28
Dividend Yield0.24%
Dividend Rate0.26
Payout Ratio20.18%

Dividends

20262×
0.13Sep 9, 20260.18Jul 20, 2026
20252×
0.13Oct 17, 20250.08Jul 25, 2025
20242×
0.12Oct 10, 20240.25Jul 18, 2024
20231×
0.20Jul 3, 2023